Pop on some sweatpants and go out to the stoop—the latest edition of Shrooms in the News has officially dropped. This month, we celebrate inroads made against Lyme disease, a federal grant that will allow Oregon Health and Science University to more efficiently track patient outcomes. And, we raise our eyebrows at some new research that isolates psilocin and wants us to trip without tripping.

Here’s your latest edition of your psilocybin therapy newspaper. 

An Anecdotal Study Reveals Oregon’s Psilocybin Therapeutic Model is Helping Alleviate Anxiety & Depression

A Low Dose (10mg) Trial Gives us More Good News about Psilocybin and OCD

Researchers at Cornell Find Neurological Basis for Psilocybin’s Efficacy Against Depression

Just like a Norman Rockwell paperboy pedaling through anytown USA, here I am with the latest edition of your psilocybin therapy newspaper. 

Just like a Norman Rockwell paperboy pedaling through anytown USA, here I am with the latest edition of your psilocybin therapy newspaper. 

Let us once again dig through the dustbin of the internet and unearth actual information about guided mushroom therapy. Behold, your 7th installment of Shrooms in the News, a bimonthly roundup of what’s happening in the world of legal psilocybin.

I’ve once again sifted through the rubble of bombastic claims, obvious clickbait and mindless chest-thumping to bring you actual news about psilocybin therapy. Behold, your 6th installment of Shrooms in the News, a bimonthly roundup of what’s happening in the world of legal mushroom therapy in Oregon.

Shrooms in the News for Spring 2025—a roundup of what’s happening in the world of legal psilocybin mushroom therapy in Oregon.